Corient Private Wealth LP purchased a new position in Envista Holdings Corporation (NYSE:NVST – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 679,511 shares of the company’s stock, valued at approximately $17,905,000. Corient Private Wealth LP owned about 0.42% of Envista as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Millennium Management LLC boosted its holdings in Envista by 1,442.7% in the fourth quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock worth $52,552,000 after acquiring an additional 2,263,712 shares in the last quarter. Holocene Advisors LP purchased a new stake in shares of Envista in the second quarter worth $43,936,000. Arrowstreet Capital Limited Partnership increased its holdings in shares of Envista by 341.5% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock valued at $72,515,000 after acquiring an additional 2,210,847 shares in the last quarter. Norges Bank bought a new position in shares of Envista during the fourth quarter valued at $45,113,000. Finally, Alliancebernstein L.P. raised its position in shares of Envista by 34.0% in the 2nd quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock worth $119,164,000 after purchasing an additional 1,547,656 shares during the last quarter.
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on NVST shares. Weiss Ratings upgraded shares of Envista from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 6th. Morgan Stanley set a $23.00 price objective on shares of Envista in a research note on Thursday, August 6th. Zacks Research raised shares of Envista from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. Wall Street Zen upgraded shares of Envista from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 22nd. Finally, BMO Capital Markets assumed coverage on shares of Envista in a report on Wednesday, July 8th. They set a “market perform” rating and a $27.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $29.31.
Insider Transactions at Envista
In related news, SVP Mischa Reis sold 8,000 shares of the business’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $27.50, for a total transaction of $220,000.00. Following the completion of the sale, the senior vice president directly owned 27,321 shares in the company, valued at approximately $751,327.50. The trade was a 22.65% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.99% of the company’s stock.
Envista Trading Down 1.1%
Shares of NYSE:NVST opened at $27.15 on Friday. The stock has a market capitalization of $4.36 billion, a price-to-earnings ratio of 46.81, a PEG ratio of 1.31 and a beta of 0.86. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.07 and a current ratio of 2.43. The stock’s 50-day simple moving average is $27.12 and its two-hundred day simple moving average is $26.38. Envista Holdings Corporation has a 52-week low of $18.77 and a 52-week high of $30.42.
Envista (NYSE:NVST – Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.34 by $0.07. Envista had a net margin of 3.33% and a return on equity of 7.88%. The firm had revenue of $730.50 million during the quarter, compared to analyst estimates of $716.11 million. During the same quarter in the prior year, the firm earned $0.26 EPS. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. Analysts expect that Envista Holdings Corporation will post 1.53 EPS for the current year.
About Envista
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Featured Articles
- Five stocks we like better than Envista
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
